Literature DB >> 21748605

Physical assessment immediately after lobectomy via miniposterolateral thoracotomy assisted by videothoracoscopy for non-small cell lung cancer.

Riichiroh Maruyama1, Junko Tanaka, Dai Kitagawa, Ryuji Ohta, Kouta Yamauchi, Hitoshi Ayabe, Hirofumi Shimazoe, Hidefumi Higashi, Yoshihiko Maehara.   

Abstract

PURPOSE: We evaluated the invasiveness of videothoracoscopy-assisted mini-posterolateral thoracotomy (VAmPLT) for non-small cell lung cancer (NSCLC).
METHODS: This study prospectively analyzed 50 NSCLC patients who underwent VAmPLT lobectomy. We measured maximal negative inspiratory pressure (PImax), maximal positive expiratory pressure (PEmax), quadriceps strength (QS), 6-min walk test (6mWT), and postoperative pain during the perioperative period. We then compared the results of the 6mWT and the postoperative pain of the VAmPLT lobectomy patients with those of a control group of 50 NSCLC patients who underwent standard posterolateral thoracotomy (PLT) techniques just prior to implementation of the VAmPLT lobectomy.
RESULTS: The PImax and PEmax at the baseline, then on postoperative days (PODs) 1, 7, and 14 were 125% ± 5% and 120% ± 4%, 69% ± 4% and 62% ± 4%, 115% ± 5% and 100% ± 4%, and 123% ± 4%, and 110% ± 4%, respectively. The QS at the baseline, then on PODs 7 and 14 was 138% ± 5%, 129% ± 6%, and 133% ± 5%, respectively. Improvement from the baseline was seen in PImax by POD 7, and in PEmax and QS by POD 14. The 6mWT results and the level of postoperative pain after VAmPLT lobectomy were superior to those after PLT.
CONCLUSIONS: The advantages of VAmPLT lobectomy over PLT include less postoperative pain and earlier recovery of physical function.

Entities:  

Mesh:

Year:  2011        PMID: 21748605     DOI: 10.1007/s00595-010-4372-3

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  10 in total

1.  Pulmonary function after lobectomy: video-assisted thoracic surgery versus thoracotomy.

Authors:  M Nakata; H Saeki; N Yokoyama; A Kurita; W Takiyama; S Takashima
Journal:  Ann Thorac Surg       Date:  2000-09       Impact factor: 4.330

2.  Reduced perioperative immune response in video-assisted versus open surgery in a rat model.

Authors:  Yoshitaka Ito; Makoto Oda; Yoshio Tsunezuka; Isao Matsumoto; Norihiko Ishikawa; Kazuyuki Kawakami; Yasuhiko Ota; Go Watanabe
Journal:  Surg Today       Date:  2009-07-29       Impact factor: 2.549

3.  The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale.

Authors:  L J DeLoach; M S Higgins; A B Caplan; J L Stiff
Journal:  Anesth Analg       Date:  1998-01       Impact factor: 5.108

4.  What is the advantage of a thoracoscopic lobectomy over a limited thoracotomy procedure for lung cancer surgery?

Authors:  H Nomori; H Horio; T Naruke; K Suemasu
Journal:  Ann Thorac Surg       Date:  2001-09       Impact factor: 4.330

5.  Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer.

Authors:  Rebecca P Petersen; DuyKhanh Pham; William R Burfeind; Steven I Hanish; Eric M Toloza; David H Harpole; Thomas A D'Amico
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

6.  Pulmonary function, postoperative pain, and serum cytokine level after lobectomy: a comparison of VATS and conventional procedure.

Authors:  I Nagahiro; A Andou; M Aoe; Y Sano; H Date; N Shimizu
Journal:  Ann Thorac Surg       Date:  2001-08       Impact factor: 4.330

7.  Unique minithoracotomy assisted by videothoracoscopy facilitates a maximal view even with a minimal wound for resection of primary lung cancer.

Authors:  I Yoshino; C Ushijima; M Tomiyasu; R Suemitsu; Y Ichinose; K Sugimachi
Journal:  Surg Endosc       Date:  2001-10-13       Impact factor: 4.584

8.  Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease.

Authors:  Elisabeth B Swallow; Diana Reyes; Nicholas S Hopkinson; William D-C Man; Raphaël Porcher; Edward J Cetti; Alastair J Moore; John Moxham; Michael I Polkey
Journal:  Thorax       Date:  2006-11-07       Impact factor: 9.139

9.  Thoracoscopic lobectomy: report on safety, discharge independence, pain, and chemotherapy tolerance.

Authors:  Daniel G Nicastri; Juan P Wisnivesky; Virginia R Litle; Jaime Yun; Cynthia Chin; Francine R Dembitzer; Scott J Swanson
Journal:  J Thorac Cardiovasc Surg       Date:  2008-03       Impact factor: 5.209

10.  Use of a Cybex NORM dynamometer to assess muscle function in patients with thoracic cancer.

Authors:  Andrew Wilcock; Matthew Maddocks; Mary Lewis; Paul Howard; Jacky Frisby; Sarah Bell; Bisharat El Khoury; Cathann Manderson; Helen Evans; Simon Mockett
Journal:  BMC Palliat Care       Date:  2008-04-10       Impact factor: 3.234

  10 in total
  4 in total

1.  Physical function and health-related quality of life in patients undergoing surgical treatment for malignant pleural mesothelioma.

Authors:  Takashi Tanaka; Shinichiro Morishita; Masaki Hashimoto; Yusuke Itani; Satoshi Mabuchi; Norihiko Kodama; Seiki Hasegawa; Kazuhisa Domen
Journal:  Support Care Cancer       Date:  2017-03-14       Impact factor: 3.603

2.  Comparison of Postoperative Quality of Life and Pain with and without a Metal Rib Spreader in Patients Undergoing Lobectomy through Axillary Mini-Thoracotomy for Stage I Lung Cancer.

Authors:  Hideo Ichimura; Keisuke Kobayashi; Masahiko Gosho; Kojiro Nakaoka; Takahiro Yanagihara; Yusuke Saeki; Yukio Sato
Journal:  Ann Thorac Cardiovasc Surg       Date:  2021-09-23       Impact factor: 1.889

3.  How does the type of thoracotomy affect the patient quality of life? A short form-36 health survey study.

Authors:  Timuçin Alar; Kenan Can Ceylan; Seyda Ors Kaya; Serpil Sevinç; Deniz Sigirli; Cemal Ozçelik
Journal:  Surg Today       Date:  2013-04-14       Impact factor: 2.549

4.  Which field walking test should be used to assess functional exercise capacity in lung cancer? An observational study.

Authors:  Catherine L Granger; Linda Denehy; Selina M Parry; Joel Martin; Tim Dimitriadis; Maeve Sorohan; Louis Irving
Journal:  BMC Pulm Med       Date:  2015-08-12       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.